Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029486
Filing Date
2022-08-15
Accepted
2022-08-15 16:03:25
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20220630.htm   iXBRL 10-Q 2587499
2 EX-10.1 scyx-ex101_42.htm EX-10.1 10594
3 EX-31.1 scyx-ex311_8.htm EX-31.1 18620
4 EX-31.2 scyx-ex312_7.htm EX-31.2 19287
5 EX-32.1 scyx-ex321_6.htm EX-32.1 9447
  Complete submission text file 0001564590-22-029486.txt   11445811

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA scyx-20220630.xsd EX-101.SCH 57711
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20220630_cal.xml EX-101.CAL 56493
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20220630_def.xml EX-101.DEF 204913
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20220630_lab.xml EX-101.LAB 475629
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20220630_pre.xml EX-101.PRE 371818
66 EXTRACTED XBRL INSTANCE DOCUMENT scyx-10q_20220630_htm.xml XML 2896708
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 221165611
SIC: 2834 Pharmaceutical Preparations